DKSH and Pfizer sign a partnership agreement in Taiwan  December 10, 2020


			
				DKSH and Pfizer sign a partnership agreement in Taiwan 

DKSH has entered a partnership agreement with Pfizer in Taiwan to support the distribution and market expansion of selected products by Pfizer.

Media release

DKSH and Pfizer sign a partnership agreement in Taiwan 

DKSH has entered a partnership agreement with Pfizer in Taiwan to support the distribution and market expansion of selected products by Pfizer.

Taiwan, December 10, 2020 – DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their business in Asia and beyond, will provide distribution and promotional services for chosen drugs by Pfizer including antibiotics, smoking cessation, vaccines and coagulants, in clinics and front door drugstores in Taiwan.

 

Pfizer has a leading portfolio of products and medicines that support wellness and prevention as well as treatment and cures for diseases across a broad range of therapeutic areas. The recently signed agreement between DKSH Taiwan and Pfizer demonstrates DKSH’s commitment to bringing high-quality medicines to the Taiwan market.

 

Cellina Yeh, Country Manager, Pfizer Taiwan commented: “With DKSH’s in-depth expertise and extensive sales and distribution network across all segments of the healthcare industry, we are confident that DKSH will accelerate the growth of our market coverage through an innovative market expansion strategy.”

 

Wennie Chang, Vice President, Business Unit Healthcare, DKSH Taiwan, said, “We are proud to partner with Pfizer in Taiwan, a company that is committed to health for all. Our dedicated specialists will drive the expansion and increase the accessibility of Pfizer’s wide range of products. Together, we will improve the well-being of patients in Taiwan.”